The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike shots, this technique offers a less invasive way to administer GLP-1 drugs. These patches steadily release the treatment through the skin offering a stable dose of the therapeutic agent, which can optimize glucos… Read More